In today's fast-paced world, respiratory health is often neglected, especially for those suffering from chronic conditions ...

The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...

Having finally won US marketing approval, Cyclopharm has signed up the nation's biggest private and public hospital groups.

In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

For surgeons already split on their preference of inhaled pulmonary vasodilator to prevent postoperative right ventricular ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...

A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.